Scienture Holdings, Inc. (SCNX) stock
SCNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.90−0.11 (-3.65%)
Close on Nov 13, 2026Market cap $119.09MP/E –Yield –
Scienture ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
For fiscal 2025 it was -$42.10M.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$42.10M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.24M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.06M | – |
| Q3 FY2016 | Sep 30, 2016 | -$238.72K | – |
See a number that looks wrong?